Stocktoria
Syndax Pharmaceuticals Inc SNDX
Syndax Pharmaceuticals Inc institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 7,906,765 | $162.3M | 9.05% |
| MILLENNIUM MANAGEMENT LLC | 2,053,960 | $44.9M | 2.35% |
| TWO SIGMA INVESTMENTS, LP | 1,578,125 | $34.5M | 1.81% |
| D. E. Shaw & Co., Inc. | 1,239,954 | $27.1M | 1.42% |
| AQR CAPITAL MANAGEMENT LLC | 853,304 | $18.7M | 0.98% |
| CITADEL ADVISORS LLC | 344,878 | $7.5M | 0.39% |
| RENAISSANCE TECHNOLOGIES LLC | 321,600 | $7.0M | 0.37% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.